A detailed history of Martingale Asset Management L P transactions in Johnson & Johnson stock. As of the latest transaction made, Martingale Asset Management L P holds 283,888 shares of JNJ stock, worth $44.1 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
283,888
Previous 329,552 13.86%
Holding current value
$44.1 Million
Previous $48.2 Million 4.49%
% of portfolio
1.08%
Previous 1.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $6.64 Million - $7.64 Million
-45,664 Reduced 13.86%
283,888 $46 Million
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $2.56 Million - $2.8 Million
-17,721 Reduced 5.1%
329,552 $48.2 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $2.62 Million - $2.75 Million
-16,897 Reduced 4.64%
347,273 $54.9 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $2.57 Million - $2.8 Million
-17,635 Reduced 4.62%
364,170 $57.1 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $2.29 Million - $2.56 Million
-14,700 Reduced 3.71%
381,805 $59.5 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $2.63 Million - $2.83 Million
-17,016 Reduced 4.11%
396,505 $65.6 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $717,336 - $856,054
4,749 Added 1.16%
413,521 $64.1 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $6.84 Million - $7.67 Million
-42,684 Reduced 9.45%
408,772 $72.2 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $1.71 Million - $1.9 Million
-10,585 Reduced 2.29%
451,456 $73.8 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $9.3 Million - $10.3 Million
-55,270 Reduced 10.68%
462,041 $82 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $8.79 Million - $9.99 Million
-55,608 Reduced 9.71%
517,311 $91.7 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $4.57 Million - $5.07 Million
-29,327 Reduced 4.87%
572,919 $98 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $16.8 Million - $18.7 Million
-103,972 Reduced 14.72%
602,246 $97.3 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $5.7 Million - $6.11 Million
-35,730 Reduced 4.82%
706,218 $116 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $2.67 Million - $2.98 Million
17,470 Added 2.41%
741,948 $122 Million
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $7.31 Million - $8.39 Million
53,299 Added 7.94%
724,478 $114 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $239,207 - $262,126
1,704 Added 0.25%
671,179 $99.9 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $1.16 Million - $1.41 Million
9,035 Added 1.37%
669,475 $94.1 Million
Q1 2020

May 11, 2020

SELL
$111.14 - $153.99 $5.25 Million - $7.27 Million
-47,199 Reduced 6.67%
660,440 $86.6 Million
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $4.06 Million - $4.66 Million
-31,818 Reduced 4.3%
707,639 $103 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $7.16 Million - $8.01 Million
56,388 Added 8.26%
739,457 $95.7 Million
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $545,321 - $599,749
4,158 Added 0.61%
683,069 $0
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $6 Million - $6.67 Million
47,706 Added 7.56%
678,911 $0
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $3.49 Million - $4.2 Million
-28,376 Reduced 4.3%
631,205 $81.5 Million
Q3 2018

Nov 09, 2018

BUY
$121.58 - $142.88 $3.21 Million - $3.77 Million
26,391 Added 4.17%
659,581 $0
Q2 2018

Aug 09, 2018

SELL
$119.4 - $131.76 $94,923 - $104,749
-795 Reduced 0.13%
633,190 $0
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $5.13 Million - $6.08 Million
41,018 Added 6.92%
633,985 $0
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $972,340 - $1.06 Million
-7,410 Reduced 1.23%
592,967 $0
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $77.7 Million - $81.3 Million
600,377
600,377 $78.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.